Replication Of An Early Evaluation Of 30-Day Readmissions Among Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran, Rivaroxaban, Apixaban, or Warfarin In The U.S
Clinical trial NCT02769078 · COMPLETED
Trial details
- NCT number
- NCT02769078
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-11-01
- Primary completion
- 2016-02-01
- Enrollment
- 14201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.